2 Trending Healthcare Stocks: Biogen Inc (BIIB), Aetna Inc (AET)

0
57

Biogen Inc (NASDAQ:BIIB):

Stock’s Trading Stats:

Biogen Inc (NASDAQ:BIIB) declined -0.70% yesterday and closed at $271.00. The company’s market capitalization is at $60.34 billion with an average trading volume of 1.73 Million. The total number of Outstanding Shares Held by the company are 219.05 Million.

Recent Press Release:

Biogen Inc. (BIIB) on April 18, 2016  research that reinforces its strong and sustained efficacy in newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients and further supports its long-term, well-characterized safety profile. These data were presented at the 68th annual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada.

Data from a post-hoc analysis show that more than half of newly diagnosed patients treated with TECFIDERA were free from relapses and disability progression for six years, reinforcing that early, effective treatment with TECFIDERA improves long-term clinical outcomes. Additional real-world data from a claims database indicate that TECFIDERA is associated with significantly lower annualized relapse rates (ARR) relative to multiple disease modifying therapies (DMTs), counting glatiramer acetate, interferon β and teriflunomide. These rates were similar between TECFIDERA and fingolimod.

In an effort to better understand the overall safety profile of TECFIDERA, data presented at AAN explore the treatment’s effects on lymphocyte profiles. The data reinforce the importance of absolute lymphocyte counts (ALC) monitoring, in line with the guidance offered in the current U.S. label, and support the known, well-characterized long-term safety profile of TECFIDERA. Biogen is committed to patient safety and continues to further study these effects in an effort to optimize patient care.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies.

Aetna Inc (NYSE:AET):

Stock’s Trading Stats:

Aetna Inc (NYSE:AET) closed at $111.47 yesterday by showing an increase of 0.91%. The total number of outstanding shares held by the company are 350.53 Million with the total market capitalization of $39.31 billion. The number of shares traded on the last trading session are 1.25 Million.

Recent Press Release:

Aetna Inc. (AET) on April 14, 2016 declared that its first-quarter 2016 results will be made public on Thursday, April 28, at 6 a.m. ET. Aetna also will host a conference call, which will start at 8:30 a.m. ET on that day.

The public may access the conference call through a live audio webcast accessible via Aetna’s Investor Information website at www.aetna.com/investor. Financial, statistical and other information, counting GAAP reconciliations, related to the conference call also will be accessible at the same website.

Anyone listening to Aetna’s call and/or webcast is encouraged to read Aetna’s 2015 Annual Report on Form 10-K, counting the talk aboution of risk factors and Aetna’s historical results of operations and financial condition contained therein. The report is on file with the Securities and Exchange Commission.